Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: Comparative analysis of the Macdonald, RECIST, RANO, and RECIST F criteria

  1. Pérez-Larraya, J.G.
  2. Lahutte, M.
  3. Petrirena, G.
  4. Reyes-Botero, G.
  5. González-Aguilar, A.
  6. Houillier, C.
  7. Guillevin, R.
  8. Sanson, M.
  9. Hoang-Xuan, K.
  10. Delattre, J.-Y.
Aldizkaria:
Neuro-Oncology

ISSN: 1522-8517,  1523-5866

Argitalpen urtea: 2012

Alea: 14

Zenbakia: 5

Orrialdeak: 667-673

Mota: Artikulua

DOI: 10.1093/NEUONC/NOS070 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus